Healthcare
Grown Rogue International Inc.(GRUSF)
Live Price
Offline$0.43
+0.00% today
1Y Change
+19.44%
Window
Jun 26, 2025 โ Jun 23, 2026
- Market Cap
- $90.00M
- Revenue Growth
- -18.0%
- EPS Growth
- +148.9%
- Dividend Yield
- 0.0%
Coverage: 248 bars ยท Jun 26, 2025 โ Jun 23, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Grown Rogue International Inc. (GRUSF) is a Healthcare stock with a market cap of $90.00M and listed on OTC. The stock last traded around $0.43 and up 19.4% across the available one-year price window (Jun 26, 2025 โ Jun 23, 2026). Baseline metrics include revenue growth of -18.0%, EPS growth of +148.9%, a dividend yield of 0.0%. What stands out right now is revenue -18.0%, EPS +148.9%, free cash flow -84.8% with operating margin -12.6% and ROIC -5.0%. Valuation already assumes a fairly strong business story at P/E 31.3 and price/sales 2.7. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines GRUSF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-18.0% vs +7.6% peer median
Operating Margin
Below sector median
-12.6% vs +19.4% peer median
P/E
Below sector median
31.3 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 11, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -18.0% and EPS is at +148.9%, with operating margin around -12.6%.
The next real check-in already has a date
The next earnings event is scheduled for Sep 1, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -4.1% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 11, 2026 | โ | -2.7% | +0.0% | +24.3% |
2025 Nov 11, 2025 | โ | +2.9% | -5.9% | -14.7% |
2025 Aug 12, 2025 | โ | +2.1% | -6.4% | +4.3% |
Benchmark Edge
GRUSF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
GRUSF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
GRUSF Max Drawdown
-46.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for GRUSF and SPY.
Company Overview
Grown Rogue International Inc.
Other OTC
Grown Rogue International Inc., through its subsidiaries, engages in growing and selling cannabis products in the United States. It offers flower products, such as indicas, sativas, and hybrids; and edibles, vape cartridges, pre-rolls, or concentrates. The company sells its products through dispensaries. Grown Rogue International Inc. is headquartered in Medford, Oregon.
- Leadership
- J. Obie Strickler
- IPO Date
- Oct 15, 2010
- Employees
- 204
- Street Address
- 550 Airport Road
- Mailing
- Medford, OR, 97504
- Region
- Medford, OR, US
- Reporting Currency
- USD
- Investor Line
- 458 226 2100
- Last Updated
- Apr 29, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 31.3
- EV/EBITDA
- 74.8
- Price/Sales
- 2.7
- Price/Book
- 4.3
Growth
- Revenue
- -18.0%
- EPS
- +148.9%
- Free Cash Flow
- -84.8%
Profitability
- Gross Margin
- 43.6%
- Operating Margin
- -12.6%
- Net Margin
- 8.8%
- ROE
- 11.6%
- ROIC
- -5.0%
Balance Sheet
- Debt/Equity
- 1.28
- Current Ratio
- 3.87
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.